Outcome of BM

You are here:

Home
Investors
Outcome of BM

Updates from Lincoln Pharmaceuticals Limited

2022-2023

Q1

Q2

Q3

Q4

Reconstitution of Committees

Updates from BSE India

Insider Trading / SAST

Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Company Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Result

Financial Results Of The Company

Board Meeting Outcome for OUTCOME OF BOARD MEETING

Board Meeting

Board Meeting Intimation for Board Meeting Intimation For Inter-Alia To Consider And Approve The Un-Audited Financial Results For The Quarter And Nine-Months Ended On December 31, 2022.

AGM/EGM

Corp. Action